{"url":"https://lda.senate.gov/api/v1/filings/39dcfcb1-16fc-4f0a-a0bb-eae89c094ed6/","filing_uuid":"39dcfcb1-16fc-4f0a-a0bb-eae89c094ed6","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2008,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/39dcfcb1-16fc-4f0a-a0bb-eae89c094ed6/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Brette McClellan, Director, Health Policy Government Relations","dt_posted":"2008-07-21T18:59:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"6201 SOUTH FREEWAY, TA5-6","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"FORT WORTH","registrant_state":"TX","registrant_zip":"76134","registrant":{"id":314534,"url":"https://lda.senate.gov/api/v1/registrants/314534/","house_registrant_id":39377,"name":"ALCON LABORATORIES, INC.","description":"Pharmaceutical and medical device manufacturer","address_1":"6201 SOUTH FREEWAY, TA5-6","address_2":null,"address_3":null,"address_4":null,"city":"FORT WORTH","state":"TX","state_display":"Texas","zip":"76134-2099","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRETTE MCCLELLAN","contact_telephone":"+1 817-568-6349","dt_updated":"2022-04-06T16:08:17.701104-04:00"},"client":{"id":185017,"url":"https://lda.senate.gov/api/v1/clients/185017/","client_id":12,"name":"ALCON LABORATORIES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-01-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presciption drug importation.","foreign_entity_issues":"Nestle S.A. is a foreign entity that as of June 30, 2008 owned 76.85% of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.","lobbyists":[{"lobbyist":{"id":39608,"prefix":null,"prefix_display":null,"first_name":"BRETTE","nickname":null,"middle_name":null,"last_name":"MCCLELLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Prescription drug importation and issues concerning anti-counterfeiting and pedigree of prescription drugs.","foreign_entity_issues":"Nestle S.A. is a foreign entity that as of June 30, 2008 owned 76.85% of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.","lobbyists":[{"lobbyist":{"id":39608,"prefix":null,"prefix_display":null,"first_name":"BRETTE","nickname":null,"middle_name":null,"last_name":"MCCLELLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 6331/ S. 3101, The Medicare Improvements for Patients & Providers Act; S. 3118, Preserving Access to Medicare Act of\n2008, pay for performance issues.","foreign_entity_issues":"Nestle S.A. is a foreign entity that as of June 30, 2008 owned 76.85% of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.","lobbyists":[{"lobbyist":{"id":39608,"prefix":null,"prefix_display":null,"first_name":"BRETTE","nickname":null,"middle_name":null,"last_name":"MCCLELLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}